These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35393922)

  • 1. Comparison of health-oriented cross-regional allocation strategies for the COVID-19 vaccine: a mathematical modelling study.
    Yang T; Deng W; Liu Y; Deng J
    Ann Med; 2022 Dec; 54(1):941-952. PubMed ID: 35393922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Foy BH; Wahl B; Mehta K; Shet A; Menon GI; Britto C
    Int J Infect Dis; 2021 Feb; 103():431-438. PubMed ID: 33388436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment.
    Libotte GB; Lobato FS; Platt GM; Silva Neto AJ
    Comput Methods Programs Biomed; 2020 Nov; 196():105664. PubMed ID: 32736332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the United States COVID-19 vaccine allocation strategy.
    Islam MR; Oraby T; McCombs A; Chowdhury MM; Al-Mamun M; Tyshenko MG; Kadelka C
    PLoS One; 2021; 16(11):e0259700. PubMed ID: 34788345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
    Shen M; Zu J; Fairley CK; Pagán JA; An L; Du Z; Guo Y; Rong L; Xiao Y; Zhuang G; Li Y; Zhang L
    Vaccine; 2021 Apr; 39(16):2295-2302. PubMed ID: 33771391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology.
    Caldwell JM; Le X; McIntosh L; Meehan MT; Ogunlade S; Ragonnet R; O'Neill GK; Trauer JM; McBryde ES
    Paediatr Respir Rev; 2021 Sep; 39():32-39. PubMed ID: 34417121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.
    Cattaneo A; Vitali A; Mazzoleni M; Previdi F
    Comput Methods Programs Biomed; 2022 Sep; 224():107029. PubMed ID: 35908330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal vaccination strategies for COVID-19 in population migration between two regions scenario.
    Zuo C; Ling Y; Guo Y; Zhang M; Meng Z; Xiang G
    Hum Vaccin Immunother; 2023 Aug; 19(2):2223108. PubMed ID: 37350470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRSi-vaccine dynamical model for the Covid-19 pandemic.
    Batistela CM; Correa DPF; Bueno ÁM; Piqueira JRC
    ISA Trans; 2023 Aug; 139():391-405. PubMed ID: 37217378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Hogan AB; Winskill P; Watson OJ; Walker PGT; Whittaker C; Baguelin M; Brazeau NF; Charles GD; Gaythorpe KAM; Hamlet A; Knock E; Laydon DJ; Lees JA; Løchen A; Verity R; Whittles LK; Muhib F; Hauck K; Ferguson NM; Ghani AC
    Vaccine; 2021 May; 39(22):2995-3006. PubMed ID: 33933313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols.
    Shamsi Gamchi N; Esmaeili M
    Eur J Health Econ; 2023 Jun; 24(4):633-646. PubMed ID: 35900675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes.
    Cao W; Zhu J; Wang X; Tong X; Tian Y; Dai H; Ma Z
    Front Public Health; 2022; 10():921855. PubMed ID: 35812517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of COVID-19 interventions: A mathematical modeling approach.
    Kim JE; Choi H; Choi Y; Lee CH
    Front Public Health; 2022; 10():993745. PubMed ID: 36172208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Vaccination Prioritization Strategies for COVID-19 in South Africa Based on Age-Specific Compartment Model.
    Zuo C; Meng Z; Zhu F; Zheng Y; Ling Y
    Front Public Health; 2022; 10():876551. PubMed ID: 35784231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic modelling to identify mitigation strategies for the COVID-19 pandemic.
    Gorji H; Arnoldini M; Jenny D; Hardt WD; Jenny P
    Swiss Med Wkly; 2021 Apr; 151():w20487. PubMed ID: 33945149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.